Seattle Genetics, Inc. (SGEN)


NasdaqGS - NasdaqGS Real Time Price. Currency in USD
47.74-0.05 (-0.10%)
As of 1:19 PM EDT. Market open.
People also watch:
IMGNBMRNINCYMDVNALNY
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Open47.67
Prev Close47.79
Bid47.80 x 100
Ask47.85 x 200
Day's Range47.61 - 48.57
52wk Range26.02 - 49.66
1y Target EstN/A
Market Cap6.71B
P/E Ratio (ttm)-62.49
Beta1.84
Volume273,419
Avg Vol (3m)736,960
Dividend & YieldN/A (N/A)
Earnings DateN/A
Trade prices are not sourced from all markets
  • Barrons.comyesterday

    4 Biotech Buyout Targets for Gilead, Sanofi After Medivation Miss

    Yesterday, we highlighted six stocks that the folks at Citigroup contend could be buyout targets following Pfizer's (PFE) $14 billion purchase of Medivation (MDVN). Today, Gabelli's Jing He offers four ...

  • Capital Cube15 days ago

    ETF’s with exposure to Seattle Genetics, Inc. : August 9, 2016

    Categories: ETFs Yahoo Finance Click here to see latest analysis ETF’s with exposure to Seattle Genetics, Inc. Here are 5 ETF’s with the largest exposure to SGEN-US. Comparing the performance and risk of Seattle Genetics, Inc. with the ETF’s that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)

  • Seattle Genetics, Inc. :SGEN-US: Earnings Analysis: Q2, 2016 By the Numbers : August 8, 2016
    Capital Cube16 days ago

    Seattle Genetics, Inc. :SGEN-US: Earnings Analysis: Q2, 2016 By the Numbers : August 8, 2016

    Categories: Yahoo Finance Click here to see latest analysis Seattle Genetics, Inc. reports financial results for the quarter ended June 30, 2016. We analyze the earnings along side the following peers of Seattle Genetics, Inc. – ImmunoGen, Inc., Biogen Inc., Celgene Corporation, Pfizer Inc., GlaxoSmithKline plc Sponsored ADR, Bristol-Myers Squibb Company, AbbVie, Inc. and Progenics Pharmaceuticals, Inc. (IMGN-US, ... Read more (Read more...)